Literature DB >> 12799616

Delta sleep response to metyrapone in post-traumatic stress disorder.

Thomas C Neylan1, Maryanne Lenoci, Melissa L Maglione, Nicholas Z Rosenlicht, Thomas J Metzler, Christian Otte, Frank B Schoenfeld, Rachel Yehuda, Charles R Marmar.   

Abstract

Metyrapone blocks cortisol synthesis, which results in the stimulation of hypothalamic cortiocotropin-releasing factor (CRF) and a reduction in delta sleep. We examined the effect of metyrapone administration on endocrine and sleep measures in male subjects with and without chronic PTSD. We hypothesized that metyrapone would result in a decrease in delta sleep and that the magnitude of this decrease would be correlated with the endocrine response. Finally, we utilized the delta sleep response to metyrapone as an indirect measure of hypothalamic CRF activity and hypothesized that PTSD subjects would have decreased delta sleep at baseline and a greater decrease in delta sleep induced by metyrapone. Three nights of polysomnography were obtained in 24 male subjects with combat-related PTSD and 18 male combat-exposed normal controls. On day 3, metyrapone was administered during normal waking hours until habitual sleep onset preceding night 3. Endocrine responses to metyrapone were measured in plasma obtained the morning following sleep recordings, the day before and after administration. Repeated measures ANOVAs were conducted to compare the endocrine and sleep response to metyrapone in PTSD and controls. PTSD subjects had significantly less delta sleep as indexed by stages 3 and 4, and total delta integrated amplitude prior to metyrapone administration. There were no differences in premetyrapone cortisol or ACTH levels in PTSD vs controls. PTSD subjects had a significantly decreased ACTH response to metyrapone compared to controls. Metyrapone caused an increase in awakenings and a marked decrease in quantitative measures of delta sleep that was significantly greater in controls compared to PTSD. The decline in delta sleep was significantly associated with the magnitude of increase in both 11-deoxycortisol and ACTH. The results suggest that the delta sleep response to metyrapone is a measure of the brain response to increases in hypothalamic CRF. These data also suggest that the ACTH and sleep EEG response to hypothalamic CRF is decreased in PTSD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12799616     DOI: 10.1038/sj.npp.1300215

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  18 in total

1.  Adaptation effects to sleep studies in participants with and without chronic posttraumatic stress disorder.

Authors:  Ellen Herbst; Thomas J Metzler; Maryann Lenoci; Shannon E McCaslin; Sabra Inslicht; Charles R Marmar; Thomas C Neylan
Journal:  Psychophysiology       Date:  2010-11       Impact factor: 4.016

2.  Susceptibility to PTSD-like behavior is mediated by corticotropin-releasing factor receptor type 2 levels in the bed nucleus of the stria terminalis.

Authors:  Maya Lebow; Adi Neufeld-Cohen; Yael Kuperman; Michael Tsoory; Shosh Gil; Alon Chen
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

3.  Sex differences in neurosteroid and hormonal responses to metyrapone in posttraumatic stress disorder.

Authors:  Sabra S Inslicht; Anne Richards; Erin Madden; Madhu N Rao; Aoife O'Donovan; Lisa S Talbot; Evelyn Rucker; Thomas J Metzler; Richard L Hauger; Thomas C Neylan
Journal:  Psychopharmacology (Berl)       Date:  2014-06-21       Impact factor: 4.530

Review 4.  Sleep and mental disorders: A meta-analysis of polysomnographic research.

Authors:  Chiara Baglioni; Svetoslava Nanovska; Wolfram Regen; Kai Spiegelhalder; Bernd Feige; Christoph Nissen; Charles F Reynolds; Dieter Riemann
Journal:  Psychol Bull       Date:  2016-07-14       Impact factor: 17.737

5.  A rodent model of traumatic stress induces lasting sleep and quantitative electroencephalographic disturbances.

Authors:  Michael T Nedelcovych; Robert W Gould; Xiaoyan Zhan; Michael Bubser; Xuewen Gong; Michael Grannan; Analisa T Thompson; Magnus Ivarsson; Craig W Lindsley; P Jeffrey Conn; Carrie K Jones
Journal:  ACS Chem Neurosci       Date:  2015-01-28       Impact factor: 4.418

6.  Altered overnight levels of pro-inflammatory cytokines in men and women with posttraumatic stress disorder.

Authors:  Andreas Küffer; Laura D Straus; Aric A Prather; Sabra S Inslicht; Anne Richards; Judy K Shigenaga; Erin Madden; Thomas J Metzler; Thomas C Neylan; Aoife O'Donovan
Journal:  Psychoneuroendocrinology       Date:  2018-12-05       Impact factor: 4.905

7.  Sleep and hypothalamic pituitary adrenal axis responses to metyrapone in posttraumatic stress disorder.

Authors:  Sabra S Inslicht; Madhu N Rao; Anne Richards; Aoife O'Donovan; Carolyn J Gibson; Tierney Baum; Thomas J Metzler; Thomas C Neylan
Journal:  Psychoneuroendocrinology       Date:  2017-12-07       Impact factor: 4.905

8.  Sex differences in objective measures of sleep in post-traumatic stress disorder and healthy control subjects.

Authors:  Anne Richards; Thomas J Metzler; Leslie M Ruoff; Sabra S Inslicht; Madhu Rao; Lisa S Talbot; Thomas C Neylan
Journal:  J Sleep Res       Date:  2013-06-14       Impact factor: 3.981

9.  Anger expression and sleep quality in patients with coronary heart disease: findings from the Heart and Soul Study.

Authors:  Catherine M Caska; Bethany E Hendrickson; Michelle H Wong; Sadia Ali; Thomas Neylan; Mary A Whooley
Journal:  Psychosom Med       Date:  2009-02-27       Impact factor: 4.312

10.  Role of corticosterone on sleep homeostasis induced by REM sleep deprivation in rats.

Authors:  Ricardo Borges Machado; Sergio Tufik; Deborah Suchecki
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.